NASDAQ:ROSG (ROSG) (ROSG) Stock Price, News & Analysis → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Free ROSG Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$0.42▼$0.4450-Day Range$0.43▼$0.4352-Week Range$0.23▼$2.75Volume169,599 shsAverage Volume81,512 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get (ROSG) alerts: Email Address Ad Traders Agencytop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution… About (ROSG) Stock (NASDAQ:ROSG)Rosetta Genomics Ltd. provides therapeutic, diagnostic product development and medical research services. The company develops and commercializes new diagnostic tests based on various genomics markers, including DNA, microRNA and protein biomarkers and using various technologies, including, qPCR, microarrays, next generation sequencing and fluorescence in situ hybridization. It offers proprietary microRNA technologies, such as Rosetta Cancer Origin, mi-KIDNEY, and RosettaGX Reveal Test. The company was founded by Isaac Bentwich on March 9, 2000 and is headquartered in Rehovot, Israel.Read More Ad Traders Agencytop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution… ROSG Stock News HeadlinesFebruary 27, 2024 | morningstar.comRosetta Genomics Ltd ROSGQOctober 7, 2023 | bizjournals.comLife science company founder: Lowering cost of DNA sequencing leads to groundbreaking advancements in personalized medicineApril 25, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.September 15, 2023 | msn.comWhat Do You Say on Rosh Hashanah? Blessings, Prayers, Greetings for HolidaySeptember 15, 2023 | msn.comRosh Hashanah 2023: What to know about Judaism's holiest dayApril 27, 2023 | finance.yahoo.comAI (Artificial Intelligence) in Genomics Market Research Report 2023April 25, 2023 | marketwatch.comLaboratory Developed Test Market Growth and Forecast Till 2031April 21, 2023 | benzinga.comThe Global Genetic Analysis Market size is expected to reach $22.31 billion by 2028 | Brandessence Market ResearchApril 25, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.March 29, 2023 | marketwatch.comLaboratory Developed Test Market Major Players, Anlysis and Forecast till 2031March 26, 2023 | marketwatch.comLaboratory-developed Testing Market Size and Forecast till 2030February 23, 2023 | finance.yahoo.comGlobal Consumer Genomics Market (2022 to 2027) - Featuring 23andMe, Ancestry, Color Health and Helix OpCo Among OthersFebruary 20, 2023 | marketwatch.comMicroRNA Market to Grow Significantly by Leading Players 2023 to 2028February 19, 2023 | marketwatch.comGlobal MicroRNA Market Report Historical, Current, and Projected Size, in terms of value 2030 By VMReportsFebruary 17, 2023 | marketwatch.comProstate Cancer Screening Market Size Related To Time And Cost Is Expected To Grow The Industry In Upcoming Years To 2027February 17, 2023 | marketwatch.comProstate Cancer Screening Market Outlook 2023 and Forecast to 2028 with Top Countries DataFebruary 15, 2023 | marketwatch.comLaboratory Developed Test Market Massive Growth Strikes Due To Technological Innovation During 2023-2028January 31, 2023 | marketwatch.comProstate Cancer Screening Market Growth, Opportunity, Trends, Service, Forecast To 2028January 19, 2023 | finance.yahoo.comGlobal Plant Genomics Market to Reach $14 Billion by 2027January 14, 2023 | thestreet.comRosetta Genomics (ROSG) Stock Closed Up on Cantor Fitzgerald RatingJanuary 11, 2023 | marketwatch.comLaboratory Developed Test Market : Projections and Regional Outlook, Depth Study, Analysis, Key Drivers, Top Players, Trends and Forecast 2023-2029January 5, 2023 | finance.yahoo.comSpatial Genomics and Transcriptomics Market worth $800 million by 2027 - Exclusive Report by MarketsandMarkets™December 9, 2022 | marketwatch.comMarket Research Report: Future Trends in the Kidney Cancer Diagnostics Industry from 2022 to 2028.December 6, 2022 | marketwatch.comProstate Cancer Screening Market 2022 Report Offers Key Futuristic Top Trends And Competitive Landscape By 2028December 5, 2022 | marketwatch.comProstate Cancer Screening Market 2023 Expected to Reach Significant Rate by 2025December 3, 2022 | msn.comMartin Dubravka makes transfer admission and explains why he joined Manchester UnitedNovember 12, 2022 | finance.yahoo.comGovernment of Canada invests over $5.6 million to help early-stage genomics companies bring new products to marketSee More Headlines Receive ROSG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (ROSG) and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/19/2016Today4/24/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical Preparations Sub-IndustryN/A Current SymbolNASDAQ:ROSG CUSIPN/A CIK1362959 Webwww.rosettagenomics.com Phone972732220700FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report Key ExecutivesRon KalfusChief Financial OfficerKey CompetitorsContext TherapeuticsNASDAQ:CNTXGrifolsNASDAQ:GRFSLAVA TherapeuticsNASDAQ:LVTXMainz BiomedNASDAQ:MYNZNLS PharmaceuticsNASDAQ:NLSPView All Competitors ROSG Stock Analysis - Frequently Asked Questions How were (ROSG)'s earnings last quarter? (ROSG) (NASDAQ:ROSG) posted its earnings results on Thursday, May, 19th. The medical research company reported ($0.18) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.16) by $0.02. The medical research company had revenue of $2.60 million for the quarter, compared to analyst estimates of $3.36 million. What other stocks do shareholders of (ROSG) own? Based on aggregate information from My MarketBeat watchlists, some companies that other (ROSG) investors own include Agenus (AGEN), Bausch Health Companies (BHC), Endocyte (ECYT), Intercept Pharmaceuticals (ICPT), Amicus Therapeutics (FOLD), BIOLASE (BIOL), EyePoint Pharmaceuticals (EYPT), OPKO Health (OPK), (SCMP) (SCMP) and Sarepta Therapeutics (SRPT). This page (NASDAQ:ROSG) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyPrepare for a recession unlike any otherAmerican Hartford Gold GroupWill this $2 AI stock double overnight?Behind the MarketsRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (ROSG) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
